Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

23. Februar 2026 14:47 ET | Quelle: Bernstein Liebhard LLP

CORCEPT THERAPEUTICS INCORPORATED (CORT) INVESTOR ALERT Investors With Large Losses in Corcept Therapeutics Incorporated Should Contact Bernstein Liebhard LLP To Discuss Their Rights

Corcept Shareholders Between October 31, 2024 and December 30, 2025 - Contact Bernstein Liebhard For More Information Regarding Shareholder Lawsuit
20. Februar 2026 20:28 ET | Quelle: Robbins Geller Rudman & Dowd LLP

INVESTOR ALERT: Corcept Therapeutics Incorporated Investors with Substantial Losses Have Opportunity to Lead the Corcept Class Action Lawsuit – RGRD Law

The lawsuit alleges that defendants failed to disclose that the FDA raised concerns about the adequacy of evidence supporting relacorilant’s NDA.
19. Februar 2026 08:19 ET | Quelle: Bernstein Liebhard LLP

CORCEPT THERAPEUTICS INCORPORATED (NASDAQ: CORT) INVESTIGATION ALERT: Bernstein Liebhard is Investigating Possible Securities Claims against Corcept Therapeutics Incorporated

Corcept Therapeutics Shareholders - Contact Bernstein Liebhard For More Information Regarding Shareholder Investigation
17. Februar 2026 08:16 ET | Quelle: Bernstein Liebhard LLP

CORCEPT THERAPEUTICS INCORPORATED (NASDAQ: CORT) INVESTIGATION ALERT: Bernstein Liebhard is Investigating Possible Securities Claims against Corcept Therapeutics Incorporated

Corcept Therapeutics Shareholders - Contact Bernstein Liebhard For More Information Regarding Shareholder Investigation
12. Februar 2026 10:12 ET | Quelle: Bernstein Liebhard LLP

CORCEPT THERAPEUTICS INCORPORATED (NASDAQ: CORT) INVESTIGATION ALERT: Bernstein Liebhard is Investigating Possible Securities Claims against Corcept Therapeutics Incorporated

Corcept Therapeutics Shareholders - Contact Bernstein Liebhard For More Information Regarding Shareholder Investigation
10. Februar 2026 10:47 ET | Quelle: Bernstein Liebhard LLP

CORCEPT THERAPEUTICS INCORPORATED (NASDAQ: CORT) INVESTIGATION ALERT: Bernstein Liebhard is Investigating Possible Securities Claims against Corcept Therapeutics Incorporated

Corcept Therapeutics Shareholders - Contact Bernstein Liebhard For More Information Regarding Shareholder Investigation
05. Februar 2026 10:47 ET | Quelle: Bernstein Liebhard LLP

CORCEPT THERAPEUTICS INCORPORATED (NASDAQ: CORT) INVESTIGATION ALERT: Bernstein Liebhard is Investigating Possible Securities Claims against Corcept Therapeutics Incorporated

Corcept Therapeutics Shareholders - Contact Bernstein Liebhard For More Information Regarding Shareholder Investigation
02. Februar 2026 03:33 ET | Quelle: Bernstein Liebhard LLP

CORCEPT THERAPEUTICS INCORPORATED (NASDAQ: CORT) INVESTIGATION ALERT: Bernstein Liebhard is Investigating Possible Securities Claims against Corcept Therapeutics Incorporated

Corcept Therapeutics Shareholders - Contact Bernstein Liebhard For More Information Regarding Shareholder Investigation
30. Januar 2026 11:27 ET | Quelle: Bernstein Liebhard LLP

CORCEPT THERAPEUTICS INCORPORATED (NASDAQ: CORT) INVESTIGATION ALERT: Bernstein Liebhard is Investigating Possible Securities Claims against Corcept Therapeutics Incorporated

Corcept Therapeutics Shareholders - Contact Bernstein Liebhard For More Information Regarding Shareholder Investigation
08. Januar 2026 16:26 ET | Quelle: Bragar Eagel & Squire

CORCEPT ALERT: Bragar Eagel & Squire, P.C. is Investigating Corcept Therapeutics Incorporated on Behalf of Corcept Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Corcept (CORT) To Contact Him Directly To Discuss Their Options If you purchased or...